Morgan Stanley Lowers United Health Price Target to $325, Maintains Overweight

UnitedHealth Group Incorporated (NYSE:UNH) is one of the stocks on Jim Cramer’s and analysts’ radar. On August 20, Morgan Stanley reduced its price target on UNH shares to $325 from $342 and maintained an Overweight rating. The firm revised its estimates to reflect a longer turnaround timeline. It noted that its illustrative path to 2027 EPS suggests potential upside to current Street expectations, while highlighting uncertainties related to Medicare Star ratings and possible changes in regulation and reimbursement.

UnitedHealth Group Incorporated (NYSE:UNH) provides health benefits, care services, pharmacy programs, and data solutions to a wide range of customers, including individuals, employers, healthcare providers, and government entities. The company offers health coverage, care delivery, consulting, software, and pharmacy management services. It should be noted that Cramer, on August 13, mentioned that the company can make a comeback. He stated:

“I think UnitedHealth’s going to work here… I think it’s going to work. I really do. Look, I’m not a believer. I don’t like the fact that they had shenanigans, but I will say this: I think that the company is run by a very good CEO. It could come back.”

While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.